BACKGROUND: We studied anomalous extracellular mRNAs in plasma from patients with diffuse large B-cell lymphoma (DLBCL) and their survival implications. mRNAs studied have been reported in the literature as markers of poor (BCL2. CCND2. MYC) and favorable outcome (LMO2. https://tftoyes.shop/product-category/energon/